Chemocentryx (CCXI) Reports Q4 EPS of 61c, Revs Double

Chemocentryx (NASDAQ: CCXI) reported Q4 EPS of $0.61, versus $0.17 reported last year. Revenue for the quarter came in at $26.1 thousand, versus $13.1 million reported last year.

For earnings history and earnings-related data on Chemocentryx (CCXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
• Mannatech (MTEX) Tops Q2 EPS by 53c